Suchergebnisse

Ergebnisse 61 - 70 von 11005520

Filteroptionen

antikörper (6481238)
biochemikalien (1234809)
chromatographie (1148)
diagnostik (6)
humandiagnostik (9293)
kits/assays (1024955)
laborbedarf (67207)
molekularbiologie (218931)
proteine/peptide (1541111)
sonstiges (400551)
veterinärdiagnostik (648)
zellen/zellkultur (23941)
zellmanipulation (72)

a. thaliana (17294)
aflatoxin (3)
african green monkey (6)
aids (hiv) (2)
algae (330)
all (27144)
all species (11)
alpaca (84)
amphibian (539)
animal (149)
arachnid (115)
archaea (13)
aspergillus (178)
aves (1325)
b. pertussis (7)
bacillus (69)
bacteria (41009)
bat (17662)
bear (2)
bee (32)
bison (22)
borrelia (1)
bovine (99342)
buffalo (17)
bv a.o. (3)
c. elegans (511)
camelus (365)
canine (79879)
carp (1)
cat (1)
cetacean (4)
chemical (69)
chicken (7)
chicken (3)
chicken igy (1)
chimeric (30)
chimp (20)
chinese hamster (145)
chk (1)
chlamydomonas reinhardtii (chlamydomonas smithii) (2)
cho (3e7 cell line) (1)
cho (s cell line) (1)
cho (s-cell line) (1)
clostridium (121)
cmv (5)
cobaye chimerized into a human igg1 (10)
common marmoset (1)
coral (1)
cow (1)
crustacean (183)
ctla4 (1)
culture (9)
deer (133)
dog (1)
donkey (528)
drosophila (12745)
duck (622)
e. coli (21973)
ebv (46)
echinoderm (28)
elephant (14)
eqine (1)
equine (38189)
eukaryotic proteins (3)
fel (1)
feline (5651)
ferret (619)
fipvn (1)
firefly (143)
fish (13235)
food (89)
frog (1358)
fungi (1186)
gallus (49340)
goat (17758)
golden hamster (351)
gorilla (391)
gp a.o. (4)
guinea pig (48709)
h. pylori (759)
hamster (18758)
hamster (all) (130)
hamster (armenian) (75)
hamster (syrian) (48)
hare (3)
hbv (17)
hcmv (60)
hcv (25)
helicobacter pylori (18)
hhv-8 (1)
hhv8 (5)
hippopotamus (13)
hirudo medicinalis (1)
hmst (1)
ho (1)
horse (2)
hpv (13)
hpv 16 (13)
hrp2 (1)
hsv (6)
hsv i (4)
hsv i & ii (1)
hsv ii (5)
hsv-1 (15)
htlv-1 (2)
hu (69)
hu a.o. (9)
hu ms rt dg pg (2)
humam (1)
human (3567824)
human hepatitis b virus (2)
human hepatitis b virus. others not tested. (1)
human hepatitis c virus (2)
human humanized (42)
human immunodeficiency virus (2)
hvc (2)
insect (6042)
invertebrate (1279)
isotype control (4)
jellyfish (275)
l. lactis (1)
lcmv (12)
limpet (5)
lizard (46)
llama (12)
m. tuberculosis (2)
mammal (2085)
marmoset (281)
mcmv (5)
meriones unguiculatus (1)
mink (253)
mm (1)
mo a.o. (3)
mole rat (2)
mollusc (70)
mongolian gerbil (6)
monkey (93085)
mouse (1942624)
mouse/human chimeric (31)
ms (46)
multiple epitope tags (1)
murine (1)
mussel (27)
mycobacterium tuberculosis (3)
naja nigricollis (6)
nematode (1)
not applicable (45)
null (2)
opossum (148)
other (21010)
others not tested (3)
others not tested. (4)
p. fluorescens (4)
p. pastoris (9)
p. pyralis (1)
p27 (1)
paramecium (27)
parasite (1202)
pd-l1 (1)
peptostreptococcus magnus (1)
photinus pyralis (1)
plant (14258)
plasmodium (75)
pneumocystis carinii (3)
polar bear (28)
por (9)
porcine (119537)
porpoise (8)
primate (58177)
protozoa (322)
pseudomonas sp (108)
pufferfish (1)
r. reniformis (2)
rabbit (75742)
rabbit + goat + mouse (1)
rabbit + mouse (1)
rabbit/mouse (2)
rabies virus (331)
rat (1515877)
rat and mouse (36)
rb (1)
rek (6)
reptile (307)
rhinoceros (43)
rodent (549)
rt (6)
s. frugiperda (2)
s. japonicum (30)
saccharomyces (145)
salamander (35)
sars-cov-2 (5)
scophthalmus maximus (turbot) (psetta maxima) (2)
scorpion (103)
sea lion (12)
seal (28)
sendai virus (1)
sh (4)
sh a.o. (4)
shark (6)
sheep (24944)
shrew (14)
snail (40)
snake (187)
staphylococcus aureus (3)
streptococcus sp (1)
sw (2)
swine (1)
syrian golden hamster (4)
t. aquaticus (4)
t. pallidum (4)
tag (108)
toxoplasma gondii (2)
treponema (1)
treponema pallidum (6)
trichnosanthin (1)
tuna (1)
turkey (15)
vacv (3)
vertebrate (123)
virus (35363)
vo (1)
vzv (1)
worm (154)
xenopus (8341)
xenopus laevis (1)
yeast (3824)
zebrafish (36327)
mouse (1)

 Fluorescence Immunoassay (1)
0 (2)
2 (6)
2D-PAGE (30)
3 infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laborato (1)
3 infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a l (1)
3 infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laborato (1)
3 infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a l (1)
3 infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laborato (1)
3 infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a l (1)
3-D Cell Cultures (9)
AGG (209)
AM (625)
AP (12961)
AT (62)
ATPase Activity Assay (9)
Activation (662)
Activity Assay (3152)
Adherent Cell Assays (2)
Adhesion (48)
AfP (1)
Apop (14)
Apoptosis Detection (26)
Array (12345)
Autophagy Detection (2)
BALF (2)
BCA (8)
BI (1)
BLI (431)
BN-PAGE (12)
Bioassay (2116)
Biochip Immunoanalyser (2)
Biochips (3)
Bioconjugation (26)
Blocking (23014)
Blot (12)
Blots (6)
Blotting (14)
Buffer (2)
CBA (278)
CFUassay (8)
CIE (6)
CISH (8)
CLIA (11190)
CLIP (3)
CM (1447)
CMCD (119)
CMIA (1)
COSTIM (247)
CQA TGY PLA EVS WPN VSV PA (1)
CS (315)
CTSeq (18)
CUT&Tag (85)
Calcium dependent (1)
Catalysis (32)
Cell Assays (79)
Cell Culture (4715)
Cell Culturing System (23)
Cell Screening (2)
Cell Separation (275)
Cell Storage (13)
Cell stimulation (1)
ChIP (7371)
Chemiluminescent (2)
CoIP (223)
Coagulation Assay (8)
Coating Material (14)
Colorimetric (93)
Colorimetric Assay (1)
Colorimetric/Fluorometric (2)
Confocal Microscopy (2)
Conjugation (170)
Control (29792)
Control for CMV and VZV assays (1)
Control for HSV-1 & HSV-2 (1)
Control or Standard (1)
Controls (22)
Correlative light and electron microscopy (CLEM) (90)
Cryosection (6)
Cryosection DOT-ELISPOT (6)
Crystallography (1834)
CyTOF (29)
Cytopathology and hematology (12)
Cytotoxic Assay (759)
DARTs Assay (1)
DID (1)
DNA Extraction/Purification (7)
DOT (10463)
DOT-ELISPOT (24)
Depletion (986)
Diagnostics (17)
Dot Blot (13)
Double Diffusion (194)
Drug Delivery (10)
E-Pair (1348)
EIA (4192)
ELISA (1780052)
ELISA based diagnostic kit (18)
ELISA-S (6)
ELISpot (3988)
EM (905)
EMSA (128)
EP (50)
Electron microscopy (28)
Enzyme Assay (150)
Epitope Tagging (29)
Ex vivo (8)
Exosome Detection (14)
Exosome Staining (380)
F) (1)
FA (26290)
FACS (31407)
FC (692290)
FCM (25)
FISH (1421)
FLISA (76990)
FRET (265)
FSEC (25)
Flow cytometry: Recommended dilution: 0.5-4 μg/ml. <br>Immunohistochemistry: Recommended dilution: 5-10 μg/ml. (2)
Fluorescence Immunoassay (1)
Fluorescence Microscopy (8)
Fluorescence microscopy (90)
Fluoro-Imaging (2)
FluoroSpot (2248)
Fluorometric (35)
FociSpot (18)
Frozen sections (496)
Functional Assay (4)
Functional Studies (6037)
Functional studies (475)
GICA (282)
Gel Supershift Assays (88)
Glycan Array (1)
Growth of B-cell hybridomas (1)
HA (32)
HAI (186)
HI (36)
HPLC (1376)
HTS (157)
HotStart PCR (1)
Hydropathy profiling (6)
IA (2399)
IAC (713)
IAP (38)
IB (856)
IC (49)
ICA (505)
ICC (383710)
ICPG (184)
ID (1208)
IDA (3)
IEM (236)
IEP (886)
IF (1090577)
IFA (19)
IFE (2)
IGS (59)
IH (2759)
IH-Fr (2314)
IHC (1023953)
IHC(P (1)
IHC-F (6)
IHC-FS (3)
IHC-Fr (122196)
IHC-P (363345)
IHC-PS (3)
IIF (4)
IL (295)
ILMA (24)
IM (427)
IP (210643)
IRMA (38)
ISH (370)
IgG and IgM detection in EIA (7)
IgG/IgM detection (3)
IgM/IgG detection (6)
Immuno assays (761)
Immuno fluorescence (350)
Immuno precipitation (373)
Immunoassay (1)
Immunoassays (5)
Immunocompetition (2416)
Immunodepletion (2353)
Immunofixation (3)
Immunofluorescence (1)
Immunoscintigraphy (10)
Immunostaining (245)
Immunosubtraction (2)
In situ hybridization (ISH) (27)
In situ hybridization (ISH) molecular pathology (8)
In vitro (1372)
In vivo (8551)
KO/KD Validated (2636)
Kinase Assay (14)
Kinetics (4262)
LCI (50)
LETIA (1)
LF (7410)
Labelling (183)
Lateral Flow Assay (26)
Light microscopy (14)
Light microscopy (LM) (99)
Live Cell Imaging (62)
MC (506)
MS (2147)
MSC Cell Assays (9)
MeDIP (32)
MeRIP (5)
Microneutralizaiton (5)
Mounting (1)
Multiplex Assay (2058)
NB (9)
NIR DYE (241)
NMR (17)
NT (34)
NTA (8)
NTRL (75)
NULL (1)
Nanomedicine (66)
NeA (9380)
Nephelometry (87)
Neu (14)
NotKnow (1)
Nucleic Acid Purification (4)
Nucleotide Array (6)
PA (10)
PAR-CLIP (1)
PBA (8)
PCR (190)
PG (2182)
PLA (1336)
PS (114)
PT (2)
Paraffin sections (299)
Photothermal (8)
Plasmonics (276)
Preclinical research (4)
Profiling (69)
Protein Array (198)
Protein Microarrays (80)
Pull-down Assay (4)
Purification (409)
QPA (2904)
RIA (4954)
RID (13)
RNA-I (123942)
RS (2)
RT-PCR (767)
Reagent Grade (1)
Real time PCR based diagnostic kit (10)
RealTime PCR (214)
Receptor Binding Assays (67)
Reference Material (76)
SAI (95)
SB (313)
SBA (4)
SBR (4046)
SDS-PAGE (125942)
SPR (54)
STORM (179)
Saliva Assays (1)
Saliva test (1)
Scanning Transmission Electron Microscopy (14)
Secondary antibody (1)
Serum folate assays (1)
Simple Western (98)
Slot blot (10)
Stabilizer and blocker (1)
Standard (14)
Standard or Control (1)
Stem cell (98)
Stim (233)
Superresolution microscopy (90)
T Cell Activation (5)
TIA (7)
TIA/Neph (1)
TLC (62)
TR-FRET (130)
The Microblot-Array assay is intended for the diagnosis of Bordetella pertussis and Bordetella parapertussis infection using IgA antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Bordetella pertussis and Bordetella parapertussis infection using IgG antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Bordetella pertussis and Bordetella parapertussis infection using IgM antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Borrelia spp. and Anaplasma phagocytophilum infections using IgG antibodies in human serum (1)
The Microblot-Array assay is intended for the diagnosis of Borrelia spp. and Anaplasma phagocytophilum infections using IgM antibodies in human serum (1)
The Microblot-Array assay is intended for the diagnosis of Chlamydia spp. infection using IgA antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Chlamydia spp. infection using IgG antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of EBV infection using IgA antibodies to recombinant antigens in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of EBV infection using IgG antibodies to recombinant antigens in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of EBV infection using IgM antibodies to recombinant antigens in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Helicobacter pylori infection using IgA antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Helicobacter pylori infection using IgG antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgA antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgG antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgM antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Yersinia enterocolitica infection using IgA antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of Yersinia enterocolitica infection using IgG antibodies in human serum or plasma in the general population. The qualitative (1)
The Microblot-Array assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to extractable nuclear antigens in human serum or plasma in the general population. The qualitative (1)
The complement factor H (1)
The immunoblot assay is intended for the diagnosis of Anaplasma phagocytophilum infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a lab (1)
The immunoblot assay is intended for the diagnosis of Anaplasma phagocytophilum infection using IgM antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a lab (1)
The immunoblot assay is intended for the diagnosis of Bordetella pertussis and Bordetella parapertussis infection using IgA antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for p (1)
The immunoblot assay is intended for the diagnosis of Bordetella pertussis and Bordetella parapertussis infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for p (1)
The immunoblot assay is intended for the diagnosis of Bordetella pertussis and Bordetella parapertussis infection using IgM antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for p (1)
The immunoblot assay is intended for the diagnosis of Borrelia spp. and Anaplasma phagocytophilum infections using IgG antibodies in human serum (1)
The immunoblot assay is intended for the diagnosis of Borrelia spp. and Anaplasma phagocytophilum infections using IgM antibodies in human serum (1)
The immunoblot assay is intended for the diagnosis of CMV infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of CMV infection using IgM antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of Chlamydia pneumoniae infection using IgA antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laborato (1)
The immunoblot assay is intended for the diagnosis of Chlamydia pneumoniae infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laborato (1)
The immunoblot assay is intended for the diagnosis of Chlamydia spp. infection using IgA antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of Chlamydia spp. infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of Chlamydia trachomatis infection using IgA antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laborat (1)
The immunoblot assay is intended for the diagnosis of Chlamydia trachomatis infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laborat (1)
The immunoblot assay is intended for the diagnosis of EBV infection using IgA antibodies to recombinant antigens in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a l (1)
The immunoblot assay is intended for the diagnosis of EBV infection using IgG antibodies to recombinant antigens in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a l (1)
The immunoblot assay is intended for the diagnosis of EBV infection using IgM antibodies to recombinant antigens in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a l (1)
The immunoblot assay is intended for the diagnosis of Helicobacter pylori infection using IgA antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laborator (1)
The immunoblot assay is intended for the diagnosis of Helicobacter pylori infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laborator (1)
The immunoblot assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgA antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laborat (1)
The immunoblot assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laborat (1)
The immunoblot assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgM antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laborat (1)
The immunoblot assay is intended for the diagnosis of Toxoplasma gondii infection using IgA antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of Toxoplasma gondii infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of Toxoplasma gondii infection using IgM antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of Treponema pallidum infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory (1)
The immunoblot assay is intended for the diagnosis of Treponema pallidum infection using IgM antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory (1)
The immunoblot assay is intended for the diagnosis of Yersinia spp. infection using IgA antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of Yersinia spp. infection using IgG antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of Yersinia spp. infection using IgM antibodies in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoblot assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to neutrophil cytoplasm and GBM in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for (1)
The immunoblot assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to nuclear antigens in human serum or plasma in the general population. The qualitative and semi-quantitative manual assay is designed for professional (1)
The immunoenzymatic assay is intended for the diagnosis (14)
The immunoenzymatic assay is intended for the diagnosis CMV infection using IgA antibodies in human serum (1)
The immunoenzymatic assay is intended for the diagnosis CMV infection using IgM antibodies in human serum (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia afzelii infection using IgG antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia afzelii infection using IgM antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia burgdorferi infection using IgG antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia burgdorferi infection using IgM antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia burgdorferi sensu lato infection using IgG antibodies in human serum (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia burgdorferi sensu lato infection using IgM antibodies in human serum (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia garinii infection using IgG antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Borrelia garinii infection using IgM antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Helicobacter pylori infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for profession (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Helicobacter pylori infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for pr (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Helicobacter pylori infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for profession (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Helicobacter pylori infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for pr (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Toxocara spp. infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of Toxocara spp. infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a lab (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of pneumococcal infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professio (1)
The immunoenzymatic assay is intended for the diagnosis and monitoring of tick-borne encephalitis infection using IgG antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis and screening CMV infection using IgG antibodies in human serum (1)
The immunoenzymatic assay is intended for the diagnosis and screening of EBV infection using IgG antibodies to a capsid antigen in human serum (2)
The immunoenzymatic assay is intended for the diagnosis and screening of EBV infection using IgG antibodies to a nuclear antigen in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for profes (1)
The immunoenzymatic assay is intended for the diagnosis and screening of EBV infection using IgG antibodies to a nuclear antigen in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed fo (1)
The immunoenzymatic assay is intended for the diagnosis and screening of HSV infection using IgG antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis and screening of HSV infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (2)
The immunoenzymatic assay is intended for the diagnosis and screening of HSV infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (2)
The immunoenzymatic assay is intended for the diagnosis and screening of Toxoplasma gondii infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional (1)
The immunoenzymatic assay is intended for the diagnosis and screening of Toxoplasma gondii infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for profe (1)
The immunoenzymatic assay is intended for the diagnosis and screening of Treponema pallidum infection using total antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a labor (1)
The immunoenzymatic assay is intended for the diagnosis and screening of Treponema pallidum infection using total antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella parapertussis infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella parapertussis infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laborat (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella parapertussis infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella parapertussis infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laborat (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella parapertussis infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella parapertussis infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laborat (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella pertussis infection using IgA antibodies in human serum or plasma in the general population. The quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella pertussis infection using IgA antibodies in human serum or plasma in the general population. The quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella pertussis infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Bordetella pertussis infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of CMV infection using IgA antibodies in human serum (1)
The immunoenzymatic assay is intended for the diagnosis of CMV infection using IgG antibodies in human serum (1)
The immunoenzymatic assay is intended for the diagnosis of CMV infection using IgM antibodies in human serum (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia pneumoniae infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a la (2)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia pneumoniae infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use (2)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia pneumoniae infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a la (2)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia pneumoniae infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use (2)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia pneumoniae infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia pneumoniae infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia spp. (LPS) infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia spp. (LPS) infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia spp. (LPS) infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia spp. (LPS) infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia spp. (LPS) infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia spp. (LPS) infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia trachomatis infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a l (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia trachomatis infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional us (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia trachomatis infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a l (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia trachomatis infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional us (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia trachomatis infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Chlamydia trachomatis infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory (1)
The immunoenzymatic assay is intended for the diagnosis of EBV infection using IgA antibodies to a capsid antigen in human serum (2)
The immunoenzymatic assay is intended for the diagnosis of EBV infection using IgG antibodies to an early antigen in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of EBV infection using IgG antibodies to an early antigen in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laborato (1)
The immunoenzymatic assay is intended for the diagnosis of EBV infection using IgM antibodies to a capsid antigen in human serum (2)
The immunoenzymatic assay is intended for the diagnosis of EBV infection using IgM antibodies to a nuclear antigen in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of EBV infection using IgM antibodies to a nuclear antigen in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laborat (1)
The immunoenzymatic assay is intended for the diagnosis of EBV infection using IgM antibodies to an early antigen in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of EBV infection using IgM antibodies to an early antigen in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laborato (1)
The immunoenzymatic assay is intended for the diagnosis of HSV infection using IgM antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis of HSV infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (2)
The immunoenzymatic assay is intended for the diagnosis of HSV infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (2)
The immunoenzymatic assay is intended for the diagnosis of Helicobacter pylori infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of IBD using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of IBD using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of IBD using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of IBD using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza A virus infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza A virus infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza A virus infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza A virus infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza A virus infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza A virus infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza B virus infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza B virus infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza B virus infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza B virus infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza B virus infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Influenza B virus infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a l (2)
The immunoenzymatic assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional us (2)
The immunoenzymatic assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a l (2)
The immunoenzymatic assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional us (2)
The immunoenzymatic assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a l (2)
The immunoenzymatic assay is intended for the diagnosis of Mycoplasma pneumoniae infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional us (2)
The immunoenzymatic assay is intended for the diagnosis of RSV infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of RSV infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of RSV infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of RSV infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of RSV infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of RSV infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Toxocara spp. infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Toxocara spp. infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Toxoplasma gondii infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Toxoplasma gondii infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Toxoplasma gondii infection using IgE antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Toxoplasma gondii infection using IgE antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Toxoplasma gondii infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of Toxoplasma gondii infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of VZV infection using IgA antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis of VZV infection using IgM antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis of Yersinia enterocolitica and Yersinia pseudotuberculosis infections using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for profe (1)
The immunoenzymatic assay is intended for the diagnosis of Yersinia enterocolitica and Yersinia pseudotuberculosis infections using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed f (1)
The immunoenzymatic assay is intended for the diagnosis of Yersinia enterocolitica and Yersinia pseudotuberculosis infections using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is d (1)
The immunoenzymatic assay is intended for the diagnosis of Yersinia enterocolitica and Yersinia pseudotuberculosis infections using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated as (1)
The immunoenzymatic assay is intended for the diagnosis of Yersinia enterocolitica and Yersinia pseudotuberculosis infections using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for profe (1)
The immunoenzymatic assay is intended for the diagnosis of Yersinia enterocolitica and Yersinia pseudotuberculosis infections using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed f (1)
The immunoenzymatic assay is intended for the diagnosis of adenovirus infections using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of adenovirus infections using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of adenovirus infections using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of adenovirus infections using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of adenovirus infections using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of adenovirus infections using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of coeliac disease and monitoring of the gluten-free diet effectiveness using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is (1)
The immunoenzymatic assay is intended for the diagnosis of coeliac disease and monitoring of the gluten-free diet effectiveness using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated (1)
The immunoenzymatic assay is intended for the diagnosis of coeliac disease and monitoring of the gluten-free diet effectiveness using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is (1)
The immunoenzymatic assay is intended for the diagnosis of coeliac disease and monitoring of the gluten-free diet effectiveness using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated (1)
The immunoenzymatic assay is intended for the diagnosis of cows milk intolerance using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of cows milk intolerance using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use in a lab (1)
The immunoenzymatic assay is intended for the diagnosis of cows milk intolerance using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of cows milk intolerance using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use in a lab (1)
The immunoenzymatic assay is intended for the diagnosis of cows milk intolerance using IgM antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of cows milk intolerance using IgM antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use in a lab (1)
The immunoenzymatic assay is intended for the diagnosis of gluten intolerance using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of gluten intolerance using IgA antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use in a labora (1)
The immunoenzymatic assay is intended for the diagnosis of gluten intolerance using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of gluten intolerance using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use in a labora (1)
The immunoenzymatic assay is intended for the diagnosis of measles infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of measles infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of mumps infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of mumps infection using IgA antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of mumps infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of mumps infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of parainfluenza virus type 1 (3)
The immunoenzymatic assay is intended for the diagnosis of parainfluenza virus types 1 (3)
The immunoenzymatic assay is intended for the diagnosis of parvovirus B19 infections using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of parvovirus B19 infections using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of parvovirus B19 infections using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of parvovirus B19 infections using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of rheumatoid arthritis using IgA antibodies to CCP2 in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a labo (1)
The immunoenzymatic assay is intended for the diagnosis of rheumatoid arthritis using IgA antibodies to rheumatoid factor in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional (1)
The immunoenzymatic assay is intended for the diagnosis of rheumatoid arthritis using IgA antibodies to rheumatoid factor in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for profe (1)
The immunoenzymatic assay is intended for the diagnosis of rheumatoid arthritis using IgG antibodies to CCP2 in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in a labo (1)
The immunoenzymatic assay is intended for the diagnosis of rheumatoid arthritis using IgG antibodies to rheumatoid factor in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional (1)
The immunoenzymatic assay is intended for the diagnosis of rheumatoid arthritis using IgG antibodies to rheumatoid factor in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for profe (1)
The immunoenzymatic assay is intended for the diagnosis of rheumatoid arthritis using IgM antibodies to rheumatoid factor in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional (1)
The immunoenzymatic assay is intended for the diagnosis of rheumatoid arthritis using IgM antibodies to rheumatoid factor in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for profe (1)
The immunoenzymatic assay is intended for the diagnosis of rubella infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of rubella infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases (ENA) using IgG antibodies to Jo-1 antigens in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for pro (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases (ENA) using IgG antibodies to Jo-1 antigens in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to Ro/SS-A antigen in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for profess (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to Ro/SS-A antigen in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to SS-B/La antigen in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for profess (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to SS-B/La antigen in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to Scl-70 antigen in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professi (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to Scl-70 antigen in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to Sm antigen in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to Sm antigen in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for prof (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to U1RNP antigen in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professio (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to U1RNP antigen in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for p (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to dsDNA antigen in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professio (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to dsDNA antigen in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for p (1)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to extractable nuclear antigens and centromere B in human serum or plasma in the general population. The semi-quantitative manual assay is designe (2)
The immunoenzymatic assay is intended for the diagnosis of systemic autoimmune diseases using IgG antibodies to extractable nuclear antigens and centromere B in human serum or plasma in the general population. The semi-quantitative semi-automated assay is (2)
The immunoenzymatic assay is intended for the diagnosis of tick-borne encephalitis infection using IgM antibodies in human serum (2)
The immunoenzymatic assay is intended for the diagnosis rheumatoid arthritis using IgA antibodies to CCP2 in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use in a (1)
The immunoenzymatic assay is intended for the diagnosis rheumatoid arthritis using IgG antibodies to CCP2 in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for professional use in a (1)
The immunoenzymatic assay is intended for the monitoring of Tetanus Toxoid using IgG antibodies in human serum or plasma in the general population. The quantitative manual assay is designed for professional use in a laboratory. (1)
The immunoenzymatic assay is intended for the monitoring of Tetanus Toxoid using IgG antibodies in human serum or plasma in the general population. The quantitative semi-automated assay is designed for professional use in a laboratory. (1)
Tissue homogenate and cell culture supernatant samples (1)
Turbidimetry (163)
Tyramide Signal Amplification (1)
Universal Transport Medium (1)
Urine testing (1)
Validation (1)
Validation testing (2)
WB (3163401)
X-ray micro-CT small animal imaging (4)
Zebrafish Cell Culture (1)
and cell culture supernatant samples. In ord (2)
and cell culture supernatant samples. This kit can also be used for in vitro quantitative determination of swine L-FABP in serum (2)
and urine samples. (2)
bio-layer interferometry (27)
biomarker (4)
blotting (1)
breast milk and cell culture supernatant samples. (4)
bronchoalveolar lavage fluid (4)
bronchoalveolar lavage fluid (BALF) and urine samples. (2)
cDNA Synthesis (1)
calculated concentrations should be multiplied with 1.8. (2)
cerebrospinal fluid (2)
cerebrospinal fluid or synovial fluid in the general population. The qualitative (2)
cerebrospinal fluid or synovial fluid in the general population. The qualitative and semi-quantitativ (2)
cerebrospinal fluid or synovial fluid in the general population. The semi-quantitative and quantitative m (2)
cerebrospinal fluid or synovial fluid in the general population. The semi-quantitative and quantitative s (2)
cerebrospinal fluid or synovial fluid in the general population. The semi-quantitative manual assay is design (4)
cerebrospinal fluid or synovial fluid in the general population. The semi-quantitative semi-au (2)
cerebrospinal fluid or synovial fluid in the general population. The semi-quantitative semi-automated assay i (4)
cryosection (20)
electron and light microscopy (3)
elisa (3)
feces (2)
hMeDIP (3)
ihc (3)
immunochemistry (1)
immunogen (37)
immunopurification (1)
including S100A8/A9 multimers. (2)
ip (4)
joint fluid and cell culture supernatant samples. (2)
lectin and alternative pathways of the complement system in serum and plasma samples. (3)
light microscopy (LM) (24)
mIF (27)
metabolism (4)
monitoring and screening of Bordetella pertussis infection using IgG antibodies in human serum or plasma in the general population. The quantitative manual assay is designed for professional use in (1)
monitoring and screening of Bordetella pertussis infection using IgG antibodies in human serum or plasma in the general population. The quantitative semi-automated assay is designed for professional (1)
monitoring and screening of Treponema pallidum infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use (1)
monitoring and screening of Treponema pallidum infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professio (1)
monitoring and screening of Treponema pallidum infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use (1)
monitoring and screening of Treponema pallidum infection using IgM antibodies in human serum or plasma in the general population. The semi-quantitative semi-automated assay is designed for professio (1)
monitoring and screening of VZV infection using IgG antibodies in human serum (2)
monitoring and screening of measles infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professiona (1)
monitoring and screening of measles infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for pro (1)
monitoring and screening of mumps infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professional (1)
monitoring and screening of mumps infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for profe (1)
monitoring and screening of rubella infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative manual assay is designed for professiona (1)
monitoring and screening of rubella infection using IgG antibodies in human serum or plasma in the general population. The semi-quantitative and quantitative semi-automated assay is designed for pro (1)
neutralisation assays (12)
organoid (175)
organoid culture (47)
plasma (38)
plasma and bronchoalveolar lavage fluid (BALF) samples. (2)
plasma and cell culture samples. (2)
plasma and cell culture supernatant samples. (8)
plasma and cell culture supernatant. (4)
plasma and serum samples. (2)
plasma and urine samples. (4)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative manual assay i (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative manual assay is (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative manual assay is designe (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative manual assay is designed for (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative manual assay is designed for profes (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative manual assay is designed for professional use in (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative semi-automated (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative semi-automated (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative semi-automated assay is (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative semi-automated assay is desig (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative semi-automated assay is designed fo (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative and quantitative semi-automated assay is designed for p (1)
plasma or cerebrospinal fluid in the general population. The semi-quantitative manual assay is designed for professional use (2)
plasma or cerebrospinal fluid in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory. (5)
plasma or cerebrospinal fluid in the general population. The semi-quantitative semi-automated assay is designed for professio (2)
plasma or cerebrospinal fluid in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laborat (3)
plasma or cerebrospinal fluid in the general population. The semi-quantitative semi-automated assay is designed for professional use in a laboratory (2)
plasma or serum. (1)
plate test (16)
qPCR based detection kit (1)
sandwich ELISA (2)
semi-quantitat (2)
semi-quantitative and quantitative automated (1)
semi-quantitative and quantitative automated a (3)
semi-quantitative and quantitative automated assay is designed for p (3)
semi-quantitative and quantitative automated assay is designed for profe (2)
semi-quantitative and quantitative automated assay is designed for profess (3)
semi-quantitative and quantitative automated assay is designed for professio (2)
semi-quantitative and quantitative automated assay is designed for professional u (2)
serum and feces samples. (2)
serum and sputum samples. (2)
sputum and cell culture supernatant samples. (2)
stem cell culture (124)
surface plasmon resonance (6)
therapeutics (10)
tissue homogenate and cell culture supernatant samples. (2)
urine (8)
urine and CSF samples. (2)
urine and cell culture supernatant samples. (6)
urine and cerebrospinal fluid samples. (2)
vaccination (6)
wb (3)
wound fluid and bronchoalveolar lavage fluid. (2)
xMAP (226)

bovine (2531)
canine (211)
equine (2170)
feline (47)
gallus (1077)
go (1)
goat (1108)
guinea pig (844)
hamster (all) (401)
hamster (armenian) (69)
hamster (syrian) (415)
human (3240)
monkey (202)
mouse (1990)
ms (3)
no (3)
no cross-adsorbtion (5475)
porcine (271)
rabbit (1677)
rat (1162)
rt (1)
sheep (1059)
test (1)

affinity purified ig (1)
anti-mcd47 (6)
anti-mox40 (8)
anti-mpd-l1 (9)
armenian hamster igg (19)
armenian hamster igg kappa (9)
armenian hamster igg1 (3)
armenian hamster igg2 (4)
armenian hamster igg2 kappa (6)
armenian hamster igg2b kappa (2)
bispecific (23)
bovine ig (2)
chimeric mab (10)
cytokeratin 8/18 - mouse igg1/k and mouse igg1/k cytokeratin 19 - mouse igg1/k (4)
drb1*01:01 (1)
drb1*04:01 (2)
drb1*15:01 (1)
f(ab')₂ fragment (57)
f(ab)2 (317)
fab fragment (2341)
goat ig (4)
goat igg (note that an adequate detection system is needed) (4)
golden syrian hamster igg (4)
guinea pig ig (6)
h-2db (3)
h-2dd (2)
h-2dk (2)
h-2kb (5)
h-2kd (3)
h-2ld (3)
hla-a*02:01 (5)
hla-a*11:01 (1)
hla-a*24:02 (6)
hla-a24:02 (1)
hla-b*07:02 (1)
hla-drb1*01:01 (1)
hla-drb1*15:01 (1)
human igg1 lambda (10)
humanized igg (4)
humanized igg1 (1)
i-ab (2)
i-ak (1)
ig (1612)
iga (484)
iga kappa (32)
iga-fc fusion (34)
iga1 (86)
iga2 (42)
igd (4)
ige (357)
ige kappa (32)
ige/k (5)
igg (33920)
igg (h+l) (1)
igg 2b (1)
igg fraction monoclonal (9)
igg half-antibody (5)
igg kappa (8)
igg+igg (4)
igg+igm+iga (h+l) (1)
igg-fc fusion (154)
igg/igg1 (1)
igg1 (261289)
igg1 (f)/igg1 (pe) (3)
igg1 (f)/igg1(pe) (1)
igg1 (f)/igg2a (pe) (1)
igg1 / igg1 / igg1 / igg1 (1)
igg1 / k (4)
igg1 / kappa (215)
igg1 / lambda (10)
igg1 half-antibody (12)
igg1 kappa (711)
igg1 lambda (16)
igg1-d265a (145)
igg1-fab (2)
igg1-fc fusion (216)
igg1-lala (8)
igg1/ igg2a (1)
igg1/2b (2)
igg1/igg2a (2)
igg1/igg2b (6)
igg1/igg2b/igg2a (4)
igg1/igg3/igm/iga (6)
igg1/k (222)
igg1/k + igg1/k (4)
igg1/k+igg2a/k (2)
igg1/kappa (51)
igg1/kappa+igg2b/kappa+igg2b/kappa (4)
igg1/l (3)
igg1a (1)
igg1k (14)
igg1kappa (4)
igg1|kappa (4)
igg2 (3561)
igg2 (igg-b) (86)
igg2/4 (2)
igg2/k (8)
igg2a (67145)
igg2a (f)/igg1 (pe) (2)
igg2a / igg1 (1)
igg2a / kappa (47)
igg2a hcd3e kih bispecific (4)
igg2a kappa (384)
igg2a kappa/igm kappa (4)
igg2a lambda (6)
igg2a mcd3e kih bispecific (32)
igg2a mcd47 kih bispecific (8)
igg2a mox40 kih bispecific (1)
igg2a mpd-l1 kih bispecific (8)
igg2a/2b (5)
igg2a/igg2b (2)
igg2a/k (46)
igg2a/kappa (16)
igg2ak (8)
igg2akappa (2)
igg2a|kappa (3)
igg2b (53638)
igg2b / kappa (14)
igg2b / lambda (2)
igg2b kappa (144)
igg2b/igg1 (4)
igg2b/k (17)
igg2b/kappa (4)
igg2beta (4)
igg2bkappa (1)
igg2c (1446)
igg2c kappa (38)
igg2z (2)
igg3 (4178)
igg3 kappa (16)
igg3-fc fusion (20)
igg4 (2091)
igg4 (igg-d) (38)
igg4-s228p (477)
igga (4)
igm (8900)
igm kappa (136)
igm-fc fusion (20)
igm/k (11)
igm|kappa (4)
igy (146)
k (2448)
kaninchen ig (3)
kaninchen igg (18)
kappa (1077)
lambda (15)
lewis rat igm (3)
lgg1 (1)
maus igg (7)
maus igg/ maus igg1 kappa/ maus igg (1)
maus igg1 (23)
maus igg1 k + igg3 (3)
maus igg1 kappa (13)
maus igg1 kappa + maus igg (3)
maus igg2a (10)
maus igg2a kappa (2)
maus igg2a kappa und igg1a kappa (3)
maus igg2a kappa und maus igg1 kappa (3)
maus igg2b (3)
mouse iga (1)
mouse igg (11)
mouse igg1 (1474)
mouse igg1 kappa (434)
mouse igg1/kappa + igg1/kappa. (4)
mouse igg2 (5)
mouse igg2a (353)
mouse igg2a kappa (108)
mouse igg2b (168)
mouse igg2b kappa (80)
mouse igg3 (26)
mouse igg3 kappa (5)
mouse igm (94)
mouse igm kappa (22)
mouse igm lambda (3)
mouse mab (12)
mouse scfv fusion with human igg1 fc (2)
multi-epitope (1)
n/a (5)
na (2)
null (1)
rabbit ig (109)
rabbit igg + mouse igg1/k & igg1/k (4)
rabbit igg + mouse igg2a (4)
rabbit igg1 + mouse igg1 (4)
rabbit mab (10)
rabbit polyclonal (27)
rabbit polyclonal f(ab)2 (1)
rabbit polyclonal f(ab)2/ rabbit polyclonal f(ab´)/mouse igg1 (1)
rabbit polyclonal f(ab)2/ rabbit polyclonal f(ab´)/mouse igg2 (1)
rat igg (4)
rat igg1 (48)
rat igg1 kappa (3)
rat igg1 lambda (4)
rat igg2a (145)
rat igg2a kappa (39)
rat igg2a lambda (3)
rat igg2b (57)
rat igg2b kappa (13)
rat igg2b lambda (4)
rat igg2c (2)
rat igm (1)
scfv fragment (6)
scfv fragment (3xflag + his) (2)
scfv fragment (his) (110)
scfv-fc (8)
sheep ig (4)
vhh (203)
vhh fragment (2)
whole igg (118)